Cowen Prime Advisors LLC Volitionrx LTD Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
A detailed history of Cowen Prime Advisors LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 178,738 shares of VNRX stock, worth $110,817. This represents 0.09% of its overall portfolio holdings.
Number of Shares
178,738
Previous 181,843
1.71%
Holding current value
$110,817
Previous $309,000
19.74%
% of portfolio
0.09%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding VNRX
# of Institutions
26Shares Held
17.8MCall Options Held
41KPut Options Held
100-
Armistice Capital, LLC New York, NY9MShares$5.58 Million0.09% of portfolio
-
Lagoda Investment Management, L.P. New York, NY6.1MShares$3.78 Million2.11% of portfolio
-
Geode Capital Management, LLC Boston, MA730KShares$452,8770.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA637KShares$394,7330.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$319,9650.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $35.5M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...